{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:16:02Z","timestamp":1794665762953,"version":"4.9.1"},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"9","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003716","name":"Korea Basic Science Institute","doi-asserted-by":"publisher","award":["2020R1A6C101A191"],"award-info":[{"award-number":["2020R1A6C101A191"]}],"id":[{"id":"10.13039\/501100003716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2022-KH129441"],"award-info":[{"award-number":["RS-2022-KH129441"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>We aimed to develop a novel therapeutic strategy for lung cancer brain metastases by leveraging the tumor-tropic properties of genetically engineered Wharton\u2019s Jelly\u2013derived mesenchymal stem cells (WJ-MSC) as vehicles for dual-agent gene therapy across the blood\u2013brain barrier. WJ-MSCs were transiently engineered using lipid nanoparticle technology to coexpress soluble TRAIL (sTRAIL) and the prodrug-activating enzyme carboxylesterase 1 (CES1). In vitro analyses assessed transfection efficiency, therapeutic protein expression, apoptosis induction, and maintenance of stemness. Tumor-homing capacity was evaluated via EGFP labeling and intracerebral tracking. Therapeutic efficacy was tested in subcutaneous and intracerebral lung cancer xenograft models using bioluminescent imaging, histopathology, and IHC. In vivo treatment included intraperitoneal CPT-11 administration to assess synergy between CES1-mediated prodrug activation and sTRAIL-induced apoptosis. Modified WJ-MSCs exhibited preserved stem cell characteristics and strong tropism toward brain tumor sites. They secreted high levels of functional sTRAIL and CES1, enabling local activation of CPT-11 into SN-38 and inducing apoptosis through death receptor signaling (DR4\/DR5). Combination therapy with WJ-MSCs-CES1.sTRAIL and CPT-11 significantly suppressed tumor growth in lung cancer brain metastasis models compared with control groups. The approach demonstrated selective cytotoxicity, minimal off-target effects, and favorable safety profiles. This study establishes a nonviral, transient gene delivery platform using autologous WJ-MSCs for dual-action gene therapy in lung cancer brain metastases. The combined use of CES1 and sTRAIL and enables precise tumor targeting and drug activation, offering a promising avenue for personalized, stem cell\u2013based treatment strategies to improve outcomes in patients with brain metastatic lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study presents a nonviral, stem cell\u2013based therapy for brain metastatic non\u2013small cell lung cancer using WJ-MSCs expressing sTRAIL and CES1. These engineered cells home to tumors, activate CPT-11, and induce apoptosis. The dual-action strategy significantly reduced brain tumor burden with minimal toxicity, demonstrating strong therapeutic potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0209","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:38:55Z","timestamp":1755790735000},"page":"1552-1565","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mesenchymal Stem Cells Expressing CES1 and Soluble TRAIL Activate CPT-11 and Induce Apoptosis in Lung Cancer Brain Metastatic Lesions"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7297-9366","authenticated-orcid":false,"given":"Dong Oh","family":"Kim","sequence":"first","affiliation":[{"name":"1Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea."},{"name":"2Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3950-4046","authenticated-orcid":false,"given":"Eun Hwa","family":"Jang","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3751-1472","authenticated-orcid":false,"given":"Young Do","family":"Kwon","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9894-7389","authenticated-orcid":false,"given":"Ji Hye","family":"Yoo","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1352-4968","authenticated-orcid":false,"given":"Xiangyu","family":"Ma","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1864-9464","authenticated-orcid":false,"given":"Ki Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"2Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9137-9019","authenticated-orcid":false,"given":"Dong Geun","family":"Hong","sequence":"additional","affiliation":[{"name":"2Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9950-1678","authenticated-orcid":false,"given":"Chung Kwon","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea."},{"name":"2Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9707-6770","authenticated-orcid":false,"given":"Hyun","family":"Nam","sequence":"additional","affiliation":[{"name":"2Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-6784","authenticated-orcid":false,"given":"Jung Won","family":"Choi","sequence":"additional","affiliation":[{"name":"3Department of Neurosurgery, Brain Tumor Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9125-1934","authenticated-orcid":false,"given":"Geun-Hyoung","family":"Ha","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea."},{"name":"2Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-405X","authenticated-orcid":false,"given":"Kyeung Min","family":"Joo","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea."},{"name":"2Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul, South Korea."},{"name":"4Stem Cell and Regenerative Medicine Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea."},{"name":"5Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea."},{"name":"6Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University (SKKU), Suwon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"2025090903065479400_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4046\/trd.2020.0134","article-title":"Recent trends of lung cancer in Korea","volume":"84","author":"Lee","year":"2021","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"2025090903065479400_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025090903065479400_bib3","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"2025090903065479400_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/978-1-59745-416-2_24","article-title":"Epidemiology of lung cancer prognosis: quantity and quality of life","volume":"471","author":"Yang","year":"2009","journal-title":"Methods Mol Biol"},{"key":"2025090903065479400_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"2025090903065479400_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/cns.13.66","article-title":"Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches","volume":"3","author":"Lukas","year":"2014","journal-title":"CNS Oncol"},{"key":"2025090903065479400_bib7","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.21037\/jtd-2019-rbmlc-11","article-title":"Supportive care for patients with brain metastases from lung cancer","volume":"13","author":"Sharma","year":"2021","journal-title":"J Thorac Dis"},{"key":"2025090903065479400_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/cancers15030722","article-title":"Advances in the molecular landscape of lung cancer brain metastasis","volume":"15","author":"Souza","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025090903065479400_bib9","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/cancers2042100","article-title":"Treatment of brain metastasis from lung cancer","volume":"2","author":"Chi","year":"2010","journal-title":"Cancers (Basel)"},{"key":"2025090903065479400_bib10","doi-asserted-by":"crossref","first-page":"20503121211034366","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med"},{"key":"2025090903065479400_bib11","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/d41586-020-03155-x","article-title":"Better treatments for lung cancer that spreads to the brain","volume":"587","author":"Healey","year":"2020","journal-title":"Nature"},{"key":"2025090903065479400_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2006.09.017","article-title":"Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential","volume":"360","author":"Smirnov","year":"2007","journal-title":"Virology"},{"key":"2025090903065479400_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3727\/096368915X686841","article-title":"Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy","volume":"24","author":"Ding","year":"2015","journal-title":"Cell Transplant"},{"key":"2025090903065479400_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.15283\/ijsc18034","article-title":"Mesenchymal stem cells from the Wharton\u2019s jelly of the human umbilical cord: biological properties and therapeutic potential","volume":"12","author":"Marino","year":"2019","journal-title":"Int J Stem Cell"},{"key":"2025090903065479400_bib15","doi-asserted-by":"crossref","first-page":"114300","DOI":"10.1016\/j.addr.2022.114300","article-title":"Mesenchymal stem cells: a living carrier for active tumor-targeted delivery","volume":"185","author":"Zhang","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"2025090903065479400_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/ijc.31113","article-title":"In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging","volume":"142","author":"Cao","year":"2018","journal-title":"Int J Cancer"},{"key":"2025090903065479400_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1200\/JOP.19.00357","article-title":"Management of brain metastases in non-small-cell lung cancer","volume":"15","author":"Ernani","year":"2019","journal-title":"J Oncol Pract"},{"key":"2025090903065479400_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/bc0155420","article-title":"Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug","volume":"12","author":"Senter","year":"2001","journal-title":"Bioconjug Chem"},{"key":"2025090903065479400_bib19","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.3390\/cells11233717","article-title":"Targeting TRAIL death receptors in triple-negative breast cancers: challenges and strategies for cancer therapy","volume":"11","author":"Kundu","year":"2022","journal-title":"Cells"},{"key":"2025090903065479400_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/ijo.2016.3525","article-title":"Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs","volume":"49","author":"Huang","year":"2016","journal-title":"Int J Oncol"},{"key":"2025090903065479400_bib21","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-03-3516","article-title":"Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy","volume":"64","author":"Shah","year":"2004","journal-title":"Cancer Res"},{"key":"2025090903065479400_bib22","first-page":"1","article-title":"Formulating and characterizing lipid nanoparticles for gene delivery using a microfluidic mixing platform","volume":"168","author":"Bailey-Hytholt","year":"2021","journal-title":"J Vis Exp"},{"key":"2025090903065479400_bib23","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.2147\/CMAR.S314060","article-title":"Treatment and prognosis of solid and cystic brain metastases in patients with non-small-cell lung cancer","volume":"13","author":"Xu","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"Suppl 5","key":"2025090903065479400_bib24","first-page":"v52","article-title":"Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies","volume":"3","author":"Myall","year":"2021","journal-title":"Neurooncol Adv"},{"key":"2025090903065479400_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ctrv.2014.03.005","article-title":"Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases","volume":"40","author":"Zimmermann","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"2025090903065479400_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cllc.2014.04.008","article-title":"Brain metastases in non-small-cell lung cancer","volume":"15","author":"Dawe","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"2025090903065479400_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025090903065479400_bib28","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/bjc.1998.362","article-title":"Determinants of CPT-11 and SN-38 activities in human lung cancer cells","volume":"77","author":"van Ark-Otte","year":"1998","journal-title":"Br J Cancer"},{"key":"2025090903065479400_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-06-3607","article-title":"Tumor-targeted enzyme\/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma","volume":"67","author":"Danks","year":"2007","journal-title":"Cancer Res"},{"key":"2025090903065479400_bib30","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.2147\/IJN.S133816","article-title":"In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes","volume":"12","author":"Chen","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"2025090903065479400_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.apsb.2021.03.043","article-title":"DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS\u2014STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"2025090903065479400_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41419-021-03567-1","article-title":"Splicing reprogramming of TRAIL\/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis","volume":"12","author":"Voss","year":"2021","journal-title":"Cell Death Dis"},{"key":"2025090903065479400_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3892\/ijo.2012.1748","article-title":"Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells","volume":"42","author":"Ouyang","year":"2013","journal-title":"Int J Oncol"},{"key":"2025090903065479400_bib34","first-page":"1577","article-title":"Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells","volume":"39","author":"Ouyang","year":"2011","journal-title":"Int J Oncol"},{"key":"2025090903065479400_bib35","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/cdd.2014.81","article-title":"Getting TRAIL back on track for cancer therapy","volume":"21","author":"Lemke","year":"2014","journal-title":"Cell Death Differ"},{"key":"2025090903065479400_bib36","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3390\/ph16081156","article-title":"Anti-cancer effect of neural stem cells transfected with carboxylesterase and sTRAIL genes in animals with brain lesions of lung cancer","volume":"16","author":"Kim","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"2025090903065479400_bib37","first-page":"1103","article-title":"Chemo-sensitization of CD133+ cancer stem cell enhances the effect of mesenchymal stem cell expressing TRAIL in non-small cell lung cancer cell lines","volume":"10","author":"Fakiruddin","year":"2021","journal-title":"Biology (Basel)"},{"key":"2025090903065479400_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.prnil.2020.07.002","article-title":"Enhanced inhibition of tumor growth using TRAIL-overexpressing adipose-derived stem cells in combination with the chemotherapeutic agent CPT-11 in castration-resistant prostate cancer","volume":"9","author":"Kim","year":"2021","journal-title":"Prostate Int"},{"key":"2025090903065479400_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000151366","article-title":"Synergism of CPT-11 and Apo2L\/TRAIL against two differentially sensitive human colon tumor xenografts","volume":"74","author":"Sugamura","year":"2008","journal-title":"Oncology"},{"key":"2025090903065479400_bib40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3892\/ijmm.2012.1105","article-title":"The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in vivo","volume":"30","author":"Zhu","year":"2012","journal-title":"Int J Mol Med"},{"key":"2025090903065479400_bib41","first-page":"6153","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand\u2019s antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11","volume":"59","author":"Gliniak","year":"1999","journal-title":"Cancer Res"},{"key":"2025090903065479400_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41420-024-01983-8","article-title":"CPT-11 mitigates autoimmune diseases by suppressing effector T cells without affecting long-term anti-tumor immunity","volume":"10","author":"Liang","year":"2024","journal-title":"Cell Death Discov"},{"key":"2025090903065479400_bib43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2147\/IJN.S435407","article-title":"Research progress of SN38 drug delivery system in cancer treatment","volume":"19","author":"Qi","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"2025090903065479400_bib44","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.trecan.2020.06.006","article-title":"TRAIL of hope meeting resistance in cancer","volume":"6","author":"Deng","year":"2020","journal-title":"Trends Cancer"},{"key":"2025090903065479400_bib45","first-page":"521","article-title":"The role of TRAIL signaling in cancer: searching for new therapeutic strategies","volume":"13","author":"Luo","year":"2024","journal-title":"Biology (Basel)"},{"key":"2025090903065479400_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ccr.2012.05.014","article-title":"Proapoptotic activation of death receptor 5 on tumor endothelial cells disrupts the vasculature and reduces tumor growth","volume":"22","author":"Wilson","year":"2012","journal-title":"Cancer Cell"},{"key":"2025090903065479400_bib47","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1535-7163.MCT-05-0414","article-title":"S-phase checkpoints regulate Apo2 ligand\/TRAIL and CPT-11-induced apoptosis of prostate cancer cells","volume":"6","author":"Ray","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"2025090903065479400_bib48","first-page":"409","article-title":"MSC based gene delivery methods and strategies improve the therapeutic efficacy of neurological diseases","volume":"23","author":"Zhou","year":"2023","journal-title":"Bioact Mater"},{"key":"2025090903065479400_bib49","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.1016\/j.biomaterials.2010.07.048","article-title":"Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors","volume":"31","author":"Roger","year":"2010","journal-title":"Biomaterials"},{"key":"2025090903065479400_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2217\/fon-2020-0727","article-title":"Revisiting the role of TRAIL\/TRAIL-R in cancer biology and therapy","volume":"17","author":"Singh","year":"2021","journal-title":"Future Oncol"},{"key":"2025090903065479400_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jconrel.2020.06.038","article-title":"In vivo gene delivery mediated by non-viral vectors for cancer therapy","volume":"325","author":"Mohammadinejad","year":"2020","journal-title":"J Control Release"},{"key":"2025090903065479400_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2021.06.020","article-title":"Synthetic modified messenger RNA for therapeutic applications","volume":"131","author":"Gao","year":"2021","journal-title":"Acta Biomater"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0209\/3644171\/crc-25-0209.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/9\/1552\/3649343\/crc-25-0209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/9\/1552\/3649343\/crc-25-0209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:07:13Z","timestamp":1757401633000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/9\/1552\/764550\/Mesenchymal-Stem-Cells-Expressing-CES1-and-Soluble"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0209","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.30083908","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083875","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083896","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083884","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083872","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083893","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083902","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083881","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083905","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083890","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083899","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30083887","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8024383","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}